Pure Global

Development and Content Validation of the Childhood Early Oral Aging Syndrome (CEOAS) Index for the Deciduous Dentition - Trial NCT06378385

Access comprehensive clinical trial information for NCT06378385 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Nove de Julho and is currently Not yet recruiting. The study focuses on Aging. Target enrollment is 6 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06378385
Not yet recruiting
behavioral
Trial Details
ClinicalTrials.gov โ€ข NCT06378385
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Development and Content Validation of the Childhood Early Oral Aging Syndrome (CEOAS) Index for the Deciduous Dentition

Study Focus

Aging

Childhood Early Oral Aging Syndrome index

Observational

behavioral

Sponsor & Location

University of Nove de Julho

Santos, Brazil

Timeline & Enrollment

N/A

May 01, 2024

Dec 20, 2024

6 participants

Primary Outcome

Development of CEOAS index

Summary

Premature, non-physiological tooth wear in childhood has numerous repercussions for oral
 health. This is a growing problem with multifactorial causes and associated with the current
 lifestyle. The aim of the present study was the development and determination of content
 validity of the Childhood Early Oral Aging Syndrome (CEOAS) index for the primary dentition
 as a diagnostic and epidemiological survey tool considering the current changes found in this
 population.

ICD-10 Classifications

Alzheimer disease
Agenesis and underdevelopment of nose
Agenesis of lung
Adult-onset Still disease
Choroidal degeneration

Data Source

ClinicalTrials.gov

NCT06378385

Non-Device Trial